cas 2088458-39-1|| where to buy tert-butyl 5-oxo-1H-pyrazole-2-carboxylate

Nom du produit:tert-butyl 5-oxo-1H-pyrazole-2-carboxylate

IUPAC Name:tert-butyl 3-oxo-2,3-dihydro-1H-pyrazole-1-carboxylate

Unité d'emballage	Stock disponible	Prix($)
CM330037-250mg	in stock	Ʃŭ
CM330037-1g	in stock	șƅǺ
CM330037-5g	in stock	ƅƏş
CM330037-10g	in stock	şŭƏ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2088458-39-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2088458-39-1; Formule moléculaire:C8H12N2O3; Point de fusion:-; Code SMILES:O=C(N(C=C1)NC1=O)OC(C)(C)C; Densité:

: Numéro de catalogue:CM330037; Poids moléculaire:184.19; Point d'ébullition:; N° Mdl:MFCD31742743; Stockage:

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Vanzacaftor; Vertex Pharmaceuticals announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor is also undergoing regulatory review in multiple other jurisdictions, including by the Food and Drug Administration (FDA) in the U.S. and by the European Medicines Agency (EMA) in the E.U.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.